ArticleClinical and experimental immunology2023

Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19.

Rohan Ameratunga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.